Therapeutics in the Treatment of COVID-19 for Children and Adolescents
Pediatric Infection & Vaccine
;
: 1-15, 2022.
Artículo
en Inglés
| WPRIM
| ID: wpr-926889
ABSTRACT
Coronavirus disease 2019 (COVID-19) presents as a mild-to-moderate respiratory illness in most children. However, a small proportion of children with COVID-19 develop severe or critical illnesses. Although pediatric clinical trials for the treatment of COVID-19 are sparse, some drugs are available for children and adolescents with severe COVID-19. This review summarizes clinical data focusing on antiviral agents and immunomodulators for use in treating COVID-19. In addition, current recommendations for therapeutics for children and adolescents with COVID-19 are discussed.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Guía de Práctica Clínica
Idioma:
Inglés
Revista:
Pediatric Infection & Vaccine
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS